Clinical trialPhase 1 / Phase 2Completed
A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy
A Phase I/II Clinical Study Using Pentamidine in Patients With Locally Advanced or Metastatic Pancreatic Cancer Undergoing Standard Therapy
- Outcome
- Finished, no results posted
- Phase
- Phase 1 / Phase 2
- Status
- Completed
- Study type
- Interventional
- Start
- January 2009
- Expected end
- June 2011
- Enrollment
- 10 participants
- Sites
- 1
- Primary outcomes
- Any severe events, tumor marker CA19-9, and tumor size (CT scan)
- Sponsor
- Industry
- Results posted
- No
- Last update
- 28 June 2011
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is to investigate the safety and possible efficacy of the use of pentamidine in the treatment of pancreatic cancer metastasis in subjects receiving standard therapy.